• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - ILLUSTRATION
Tag:

ILLUSTRATION

Health

Lutein and Zeaxanthin Supplements Enhance Teen Attention

by Chief Editor June 30, 2026
written by Chief Editor

Daily supplementation with 10 mg of lutein and 2 mg of zeaxanthin was associated with improvements in cognitive performance and macular pigment optical density (MPOD) in teenagers, according to a clinical trial published in Nutrition Research. Researchers Adrian Lopresti and Stephen Smith found that six months of supplementation was associated with changes in MPOD and improvements in attention and processing speed in adolescents who consume diets low in fruits and vegetables and spend over four hours daily on LED screens.

How Does Lutein Influence Teenage Brain Health?

Did you know? While the link between lutein and eye health was first reported in 1994 by Dr. Johanna Seddon and her co-workers at Harvard University, recent clinical focus has shifted toward its role in supporting cognitive functions like memory and executive processing in younger populations.

What Were the Results of the Recent Clinical Trial?

In a study of 82 teenagers, researchers Lopresti and Smith observed that participants receiving the Lute-gen supplement experienced significant increases in MPOD in the left and right eyes. Beyond eye health, these subjects demonstrated improved scores in tests focused on attention and processing speed compared to a placebo group. The study, funded by Bio-gen Extracts Pvt. Ltd., recorded no significant differences in non-verbal memory, visual reasoning, or performance in first-person shooter games, nor were there differences between the groups for self-reported measures of attention and sleep.

View this post on Instagram about Lopresti and Smith, Johanna Seddon
From Instagram — related to Lopresti and Smith, Johanna Seddon

How Do These Findings Compare to Previous Research?

A 2017 study from Queens University Belfast and the Waterford Institute of Technology, published in the Journal of Gerontology, found that higher blood levels of lutein and zeaxanthin may be associated with better cognition, memory, and executive function. Furthermore, a 2020 systematic review in Nutrients reported that 10 mg of daily lutein over twelve months is consistently associated with improvements in visual episodic memory, verbal episodic memory, inhibition, and attention. The current study by Lopresti and Smith is said to be the first trial to demonstrate the cognitive benefits of the carotenoid in teenagers.

Lutein and Zeaxanthin: Effective for Maintaining Eye Health? [Study 310-315 Analysis]

Pro Tips for Supporting Cognitive Health

  • Dietary Priority: Increase intake of dark green leafy vegetables, such as spinach, which are naturally rich in carotenoids.
  • Screen Management: Monitor daily exposure to LED screens, as high-usage habits may correlate with lower MPOD levels.
  • Consistency Matters: Clinical trials typically require a minimum of 90 to 180 days of supplementation to see measurable changes in MPOD and cognitive performance.

Frequently Asked Questions

Can teenagers get enough lutein from food alone?
While leafy greens are a source, NHANES data suggests that lutein is only about 12% of the carotenoids in the diets, which remains lower than the levels used in successful clinical trials, which often utilize concentrated supplementation.

Pro Tips for Supporting Cognitive Health

Does lutein improve sleep?
In the study conducted by Lopresti and Smith, researchers found no differences between the groups for self-report measures of sleep.

Are all supplements the same?
Clinical research, such as the trial published in Nutrition Research, often tests specific branded ingredients—in this case, Lute-gen—to ensure consistent dosage and purity levels.


Are you interested in the latest developments in nutritional science? Subscribe to our newsletter to receive updates on clinical trials and evidence-based health research directly to your inbox.

June 30, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Wegovy Weight-Loss Pill: Benefits, Risks, and Is It Right for You?

by Chief Editor June 16, 2026
written by Chief Editor

Wegovy has become the first semaglutide weight-loss pill licensed for use in the UK, offering an oral alternative to the existing injectable version. According to manufacturer Novo Nordisk, the medication is intended for adults with a BMI of 30 or higher, or those with a BMI of at least 27 who suffer from weight-related conditions like type 2 diabetes or hypertension. While the drug is now licensed, private providers expect availability within weeks, though it remains excluded from NHS coverage pending government negotiations.

How does the Wegovy pill compare to injectable versions?

The oral version of Wegovy utilizes the same active ingredient, semaglutide, as the weekly injection. To ensure the body absorbs the peptide, the pill is formulated with a molecule called SNAC (salcaprozate sodium). Dr. Earim Chaudry, chief medical officer at the digital health provider Voy, notes that while the mechanism is identical, the oral version requires daily administration on an empty stomach, followed by a 30-minute wait before eating. Clinical trials showed that patients taking the tablets lost an average of 16.6 percent of their body weight over 64 weeks. In contrast, real-world data for the injectable version indicates weight loss of up to 20.3 percent over 18 months, according to studies cited by Voy.

How does the Wegovy pill compare to injectable versions?
Did you know?
Eight out of 10 participants in the Wegovy pill clinical trial who had prediabetes transitioned into a normal blood sugar state during the treatment period, according to data provided by Voy.

Why are patients choosing oral medication over injections?

For many, the primary driver for choosing pills is the avoidance of needles and the reduction of social stigma. A survey conducted by Voy found that 55 percent of patients using weight-loss injectables hid the treatment from their partners. Dr. Chaudry suggests that the oral format removes the need for visible medical equipment like refrigerators or syringes, potentially increasing comfort for those who fear needles or feel judged for using weight-management drugs. Despite the appeal, industry experts caution that the pill is not necessarily cheaper. Currently, Voy lists the oral medication at £134 per month for the lowest dose, compared to £124 for the injectable.

Why are patients choosing oral medication over injections?

What are the primary risks and side effects?

Gastrointestinal issues remain the most frequent side effect for both oral and injectable semaglutide. According to trial data, 74 percent of participants taking the Wegovy pill reported nausea, vomiting, or diarrhea. While these symptoms were generally classified as mild or transient, approximately 7 percent of users discontinued the medication entirely due to these effects. Caroline Balazs, founder of the clinic SkinnyJab, warns that patients should not view the pill as a shortcut. She points out that the daily requirement to take the pill correctly—often on an empty stomach—can be more challenging for some patients than a weekly injection.

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

Are there more effective weight-loss drugs on the horizon?

While Wegovy and Mounjaro currently dominate the market, future developments may offer more significant results. A 2025 trial comparing the two drugs found that patients on tirzepatide (Mounjaro) lost 20.2 percent of their body weight, compared to 13.7 percent for those on semaglutide (Wegovy). Looking further ahead, industry observers like Balazs point to Retatrutide, a “triple agonist” drug from Eli Lilly currently in phase 3 trials. Expected for release between 2027 and 2028, this drug targets three metabolic pathways simultaneously—GLP-1, GIP, and glucagon receptors—which may offer more robust weight-loss outcomes than current single or dual-agonist therapies.

Are there more effective weight-loss drugs on the horizon?

Frequently Asked Questions

Is the Wegovy pill available on the NHS?
No. As of now, the medication is only available through private providers, and Dr. Chaudry expects it will take time for the government to reach a pricing deal with manufacturer Novo Nordisk.

Can I switch from Mounjaro to the Wegovy pill?
Medical experts like Dr. Chaudry generally advise against switching if you are already seeing stable, positive results on an injectable, as the oral version is intended primarily as an alternative for those who cannot or will not use needles.

How is this different from Rybelsus?
Rybelsus is an existing oral semaglutide medication used for type 2 diabetes. The new Wegovy pill offers higher dosage strengths, including a 25mg option, which is not available in the Rybelsus formulation.

Have you considered the shift from injectable to oral weight-loss treatments? Share your thoughts in the comments below or subscribe to our health newsletter for the latest updates on medical innovations.

June 16, 2026 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • Minors Prostitution Scandal: Footballers Linked to Investigation as Key Witnesses Testify

    July 3, 2026
  • Sara Netanyahu’s Heated Exchange With PM Steals Spotlight at Maccabiah Games

    July 3, 2026
  • Racial Disparities in Hypertension Onset Among Women

    July 3, 2026
  • Amazon’s Panos Panay on the Future of AI Gadgets

    July 3, 2026
  • Combating Child Labor: CESE Recommendations

    July 3, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

© 2026 Newsy Today. All rights reserved.
For contact, advertising, copyright, issues email: [email protected]


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World